OrthoPediatrics (NASDAQ:KIDS) Trading Down 3%

OrthoPediatrics Corp. (NASDAQ:KIDS) traded down 3% during trading on Tuesday . The company traded as low as $24.86 and last traded at $25.01. 40,415 shares traded hands during mid-day trading, a decline of 76% from the average session volume of 169,735 shares. The stock had previously closed at $25.78.

Analysts Set New Price Targets

KIDS has been the topic of a number of recent research reports. Truist Financial restated a “hold” rating and set a $30.00 price target (down from $35.00) on shares of OrthoPediatrics in a research report on Thursday, August 8th. Needham & Company LLC upped their price target on OrthoPediatrics from $37.00 to $42.00 and gave the company a “buy” rating in a research report on Tuesday, May 7th. Finally, JMP Securities reiterated a “market outperform” rating and set a $50.00 price objective on shares of OrthoPediatrics in a research report on Tuesday, May 7th.

OrthoPediatrics Stock Down 1.3 %

The company has a debt-to-equity ratio of 0.03, a current ratio of 4.45 and a quick ratio of 1.99. The company has a market capitalization of $606.45 million, a PE ratio of -26.85 and a beta of 1.19. The business’s 50 day simple moving average is $30.61 and its 200 day simple moving average is $29.75.

Institutional Trading of OrthoPediatrics

Several institutional investors have recently made changes to their positions in KIDS. Brown Advisory Inc. raised its position in OrthoPediatrics by 1.6% in the fourth quarter. Brown Advisory Inc. now owns 1,628,779 shares of the company’s stock valued at $52,952,000 after purchasing an additional 25,337 shares during the period. Braidwell LP increased its position in shares of OrthoPediatrics by 4.7% during the 4th quarter. Braidwell LP now owns 1,107,770 shares of the company’s stock worth $36,014,000 after purchasing an additional 50,000 shares during the last quarter. Vanguard Group Inc. raised its holdings in OrthoPediatrics by 1.3% in the 1st quarter. Vanguard Group Inc. now owns 883,827 shares of the company’s stock valued at $25,772,000 after buying an additional 11,100 shares during the period. Granahan Investment Management LLC lifted its position in OrthoPediatrics by 30.0% in the fourth quarter. Granahan Investment Management LLC now owns 769,245 shares of the company’s stock valued at $25,008,000 after buying an additional 177,640 shares during the last quarter. Finally, Wasatch Advisors LP boosted its stake in OrthoPediatrics by 21.2% during the first quarter. Wasatch Advisors LP now owns 501,310 shares of the company’s stock worth $14,618,000 after buying an additional 87,657 shares during the period. Hedge funds and other institutional investors own 69.05% of the company’s stock.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.